Analysen von Richard Vosser
| 19.06.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.05.20 | Roche overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.05.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 27.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 26.05.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 24.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 21.04.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 17.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 01.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.03.20 | Roche overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.03.20 | Roche overweight | JP Morgan Chase & Co. | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.02.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 11.02.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.01.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 07.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.01.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 02.01.20 | Roche overweight | JP Morgan Chase & Co. | |